Search Results

By Charles L. Bennett, MD, PhD, MPP, and Jeromie Ballreich, PhD, MHS  / February 10, 2022

Oncology Drugs With Accelerated Approval: Is It Time for a Reset?

Regulations that are developed by the U.S. Food and Drug Administration (FDA) must have some shelf-life before revisions are considered. The FDA has several mechanisms to provide patients with more rapid access to medicines. One such pathway is accelerated approval. Backward Glance at Accelerated...